Ann Beal Salamone

President of Rochal Industries LLC

Ann Beal Salamone is President of Rochal Industries LLC (San Antonio, TX), which is a global leader in commercializing technology innovations in polymer, antimicrobial and biological systems. Rochal has been privileged to have received NIH SBIR funding for four unique chemistries that are on the way or are wound care products. Salamone was elected to the National Academy of Engineering in 2016 “for development of materials for biomedical applications, personal care, electronics, and water purification.”  She has invested in, and served on, the boards for several entrepreneurial companies as well as co-founded six companies.

During her tenure as Vice President of EDC (a South Florida science & technology incubator), EDC’s clients increased aggregate revenues by more than $98 million, raised more than $74 million in outside funding, and created 5,013 jobs.

She was elected Chairman of the American Chemical Society’s Polymer Division (8,000 members), and is a co-founder of the Intersociety Polymer Education Council which has provided hands-on in-services to over 700,000 K-12 science teachers since 1991.

She is an Inaugural Fellow of ACS and a Fellow of AIMBE, the recipient of the 2002 Crystal Slipper Award “Executive Woman of the Year” and a recipient of the 2011 Healthcare Businesswomen’s Association LEAD Award.

Rochal relocated to San Antonio in 2008 and became a member of BioMed SA in 2010. Currently, Salamone is Vice Chair of the BioMed SA Board, a member of the UTSA Biomedical Engineering Advisory Board, and a member of three UT Health-San Antonio Advisory Boards related to translational clinical science and community health.


My Sessions

Lessons Learned from Successful Companies: Navigating Application and Commercialization

Coronado Room

During this session you will hear from a panel of individuals who have received NIH SBIR and/or STTR awards and are navigating the commercialization process. Take advantage of the tips shared by these panelists about their up-and-down experiences transitioning technologies from the laboratory to the market.